🔎 Trials Near Me

ホーム › 慢性骨髄単球性白血病 › ワシントン

ワシントンにおける慢性骨髄単球性白血病の臨床試験

ワシントン内の拠点で、慢性骨髄単球性白血病に関する10件の研究が参加者を募集しています。

ワシントン内の都市

公式研究テキスト（英語）

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT04375631

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/20更新 · NCT07046078

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/06/22更新 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/06/22更新 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第2相健康なボランティア歓迎
6 Months · 全性別 · 2026/05/29更新 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第1相
80歳以下 · 全性別 · 2026/05/18更新 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第1/2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/05/15更新 · NCT06928662

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Seattle Cancer Care Alliance, Seattle
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/30更新 · NCT04256317

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Fred Hutchinson Cancer Center, Seattle
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Fred Hutchinson Cancer Center, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/15更新 · NCT06462365

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。